Roche's blockbuster cancer drug Avastin has been spurned once again by Britain's health cost watchdog NICE, this time as a treatment for breast cancer.
UK's NICE rejects Roche's Avastin in breast cancer
Search Results
Do kids, men need folic acid from a pill?
With the advent of folic-acid supplementation of certain foods, few Canadians are now getting too little of the B vitamin, a new study estimates -- in findings that question the need for children and men to get additional folic acid from vitamins.
New warnings added to agents used in MRI tests
New warnings of a potentially fatal skin disease will be added to labels for imaging drugs sold by Bayer, Covidien and GE Healthcare cautioning against their use by patients with kidney disease, the U.S. Food and Drug Administration said on Thursday.
Health Highlights: Sept. 9, 2010
Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
Clinical Trials Update: Sept. 9, 2010
(HealthDay News) -- Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
Smoking Could Harm Sperm, Study Finds
THURSDAY, Sept. 9 (HealthDay News) -- Two new studies provide
evidence that smoking can harm sperm - both in smoking men who may become
fathers, and in sons born to women who smoked during pregnancy.
Health Tip: Factors That May Aggravate Acne in Women
(HealthDay News) -- Acne, the most common skin disease, is not a
dangerous condition. But it can lead to permanent scarring.
Health Care Reform: Employees Face Greater Cost-Sharing
THURSDAY, Sept. 9 (HealthDay News) -- Americans who have health
insurance through large, employer-sponsored health plans will see a number
of plan design changes in 2011, and they'll be paying more for that
coverage, employers and benefits ...
U.S. health reforms cause bump in spending: report
U.S. reforms will slightly accelerate the rise in healthcare spending, according to a survey released on Thursday, handing Republicans more ammunition as they attack the Obama administration's legislative victory.
Two gene mutations mark deadly ovarian cancer
Researchers have identified two new genetic mutations that cause a significant number of the hardest-to-treat kinds of ovarian cancer, and say they point to a new "on-off" switch for tumors.
More doctors no panacea for U.S. healthcare: report
Medicare patients with more doctors to choose from do not necessarily get more or better care, researchers reported on Thursday in an analysis demonstrating how complicated U.S. healthcare reform will be.
Post new comment